UNSPSC 51342302: Buciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C9H13N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4G4Z4676IS, chemically known as 6h-purin-6-one, 2-amino-9-(3,4-dihydroxybutyl)-1,9-dihydro-, (r)- but generally known as buciclovir, which bears US NIH Compound Identifier 65648. Buciclovir most often comes in base and triphosphate forms. European Medicines Agency schedules Buciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05943MIG.

UNSPSC 51342302 Buciclovir is a Commodity code for antiviral pharmaceutical products, but the recent state and local opportunities tagged under it do not reflect this scope — instead, the posted solicitations cover naloxone (an opioid antagonist used in overdose response) and fluoroquinolone antibiotics, neither of which are buciclovir antivirals. State and local health departments and county public health agencies use this code space to procure emergency pharmaceuticals and public health supplies, typically through cooperative purchasing vehicles such as MMCAP Infuse or direct competitive bidding. The issuing bodies include state health departments and county health and community services agencies; recent activity shows the Illinois Department of Public Health and Seminole County, Florida as active buyers in this category.

Geographic activity is concentrated in the Southeast and Midwest. The most recent relevant opportunities include the Illinois Department of Public Health's award to Chartwell Rx LLC (via MMCAP Infuse piggyback) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride totaling $2,999,999.11 over three years with an August 2026 award date, and Seminole County's IFB 60459723LAS posted June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. Both procurements emphasize volume purchasing, fixed-price contracts with renewal options, and vendor compliance with workplace drug-free certification and E-Verify requirements. The code shows sparse recent activity aligned with its nominal buciclovir scope; business development professionals should verify whether this UNSPSC designation reflects actual purchasing intent or represents a classification mismatch in the state and local system.